Pursuant to the Regulation 30 of the of the Securities and Exchange Board of India (‘SEBI’) (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Sudeep Pharma has informed that John Garcia (Vice President - Sales & Supply Chain) of Sudeep Pharma USA Inc, designated as SMP, vide his letter dated 4th February 2026 has tendered his resignation with effect from the close of business hours on 6th February, 2026. The requisite disclosure as required as per the requirement of Regulation 30 read with clause 7C of Part A of Schedule III of the Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 enclosed as AnnexureA. A copy of the said resignation letter is enclosed as Annexure-B. The above information is also being made available at the Company’s website at https://www.sudeeppharma.com/.
The above information is a part of company’s filings submitted to BSE.
